Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Miron Research and Development is a specialized dental research and education firm focused on regenerative dentistry and biomaterials. Led by Dr. Richard Miron, the company pioneers the use of Platelet-Rich Fibrin (PRF) and advanced bone grafting techniques to improve clinical outcomes in oral surgery and implantology. They provide clinical education, research services, and develop specialized medical devices under the Bio-PRF brand. Their product portfolio includes horizontal centrifuges and processing kits designed to optimize the concentration of growth factors in autologous blood concentrates. The company also focuses on the development of Bio-Fill, a natural filler for facial aesthetics derived from the patient's own blood. Through extensive academic collaborations, they maintain a strong presence in peer-reviewed literature and clinical training worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Miron Research and Development in Dentistry.